Phosphodiesterase 4 inhibitors for the treatment of asthma

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.9, 1997-09, pp. : 989-1003

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3253-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies

By Dal Piaz V. Giovannoni M.P.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 5, 2000-05 ,pp. : 463-480

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease

By Spina D.

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2575-2594

Adis International

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors and the Treatment of Asthma: Where Are We Now and Where Do We Go from Here?

By Giembycz M.A.

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 193-212

Adis International

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 385-387

Informa Healthcare

Access to resources Recommend Favorite